Animal Model Market Overview:
Animal Model Market Statistics size is expected to hold a value of about USD 3,632.48 Million by 2027 and is projected to register a CAGR of 7.8% from 2020 to 2027.
The growing use of animal models in biomedical research to establish new therapeutic approaches, understand biocompatibility during drug production, and cellular responsiveness of the implant at an early stage are driving the global animal model market. The demand for animal models in the healthcare sector is increasing as a result of all of these factors. The creation of new animal model technologies involves a large number of players. The market is growing due to increased innovation and research activity using mice models for immune diseases, cancer, rare diseases, and other research activities.
The current COVID-19 pandemic is an unparalleled public health threat, prompting an increase in vaccine and antiviral drug research and development. As a result, large numbers of animals are used to check the effectiveness and safety of vaccines and antiviral drugs prior to conducting human trials. Due to the need to perform research studies, the demand for humanized ACE2 mouse models that establish a lethal SARS-CoV infection is growing. Government and scientific research organizations are likely to increase their research expenditures in order to improve COVID-19 vaccines and treatments.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/9709
Alternatives such as cell cultures, computer models, and tissue cultures, as well as ethical concerns about using animals in science, stymie market development. Furthermore, due to the ongoing pandemic, some research institutions are unable to function normally, and some industry players are unable to meet the soaring demand, negatively impacting the animal model market value.
Animal Model Market Top Companies:
The notable players of the market are Janvier Labs (France), GenOway S.A. (France), Envigo (US), Charles River Laboratories (UK), Taconic Laboratories (UK), Transgenic, Inc. (Japan), SAGE Labs (US), Horizon Discovery (England), Crown Bioscience Inc. (US), and Harbor Antibodies Bv (A Subsidiary of Harbor BioMed) (Massachusetts). In order to increase their customer base and improve their industrial position, these businesses are focusing on strategic acquisitions, mergers, alliances, and partnerships. These players' recent investments have provided the industry with opportunities for global expansion.
Animal Model Market Segmental Analysis:
The global animal model market has been segmented based on animal type, technology, application, and end-users.
The global animal model market has been segmented, on the basis of animal type, into pigs, mice, rats, rabbits, and others. The rat segment is expected to hold the maximum share of the market throughout the forecast period. The rabbit segment is expected to be the fastest-growing during the assessment period.
On the basis of technology, the market is segmented into CRISPR and other technologies.
Based on the application, the market is segmented research and development and production and quality control.
On the basis of end-user, the market is segmented into research institutes, educational institutes, pharmaceutical companies, and contract research organizations.
Animal Model Market Regional Overview:
In the global animal model market, the Americas has the largest market share. The increase in market growth can be attributed to pharmaceutical and biotech companies raising their preclinical activities during drug production, CROs increasing their use of animal models, and the rising emphasis on personalized medicine increasing the demand for animal models in this area.
The second-largest market for animal models is Europe. Increasing healthcare innovation, a greater emphasis on developing new cancer therapeutics, and the involvement of a large number of research laboratories and healthcare companies in this area all contribute to the European market's expansion. The market for animal models in the United Kingdom has been affected by the need for better animals for the treatment of Alzheimer's disease. The European Union is also funding consortiums of academic organizations to conduct research and development on mouse models for Alzheimer's disease.
In the global animal model market, the Asia-Pacific region is expected to grow at the fastest rate. This area has seen growing market growth as a result of increased biomedical and regenerative medicine research, as well as rising medical research in countries such as China, Japan, India, and others. Increased demand for animal models has resulted from a large geriatric patient population suffering from chronic diseases that need comprehensive prevention and care. Government investment in Japan has also resulted in advances in biological science, which has increased animal adoption and demand. Furthermore, one of the major driving forces propelling the demand for animals in the area is the existence of well-established research laboratories and healthcare institutes.
Because of the region's weak healthcare infrastructure, a scarcity of qualified professionals, and limited finances, the Middle East and Africa has the smallest market share.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/animal-model-market-9709
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
